SCHEMBL3110380

SCHEMBL3110380

NC(=O)c1ccccc1[CH]C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ HPGD P15428 3/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ METAP2 P50579 1/20 0.42
▸ LMNA P02545 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ BCAT2 O15382 1/20 0.41
▸ PDK2 Q15119 1/20 0.41
▸ AKR1C3 P42330 1/20 0.40
▸ AKR1C2 P52895 1/20 0.40
▸ AKR1C1 Q04828 1/20 0.40
▸ GAA P10253 1/20 0.38
▸ CTNNB1 P35222 1/20 0.38
▸ SIRT1 Q96EB6 1/20 0.38
▸ PARP1 P09874 1/20 0.37
▸ IRAK4 Q9NWZ3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5034649 0.81 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL5034641 0.81 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL8579469 0.77 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL1415250 0.77 ALDH1A1 (0.54) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL378789 0.77 KEAP1 (0.41) ALDH1A1HPGDKDM4EHSD17B10L3MBTL1
SCHEMBL17574533 0.77 KDM4E (0.41) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL1003855 0.75 TRIM24 (0.54) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL4596579 0.75 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL1515606 0.75 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EMAPTTSHR
SCHEMBL16681377 0.75 ALDH1A1 (0.46) ALDH1A1KDM4EMAPTLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324250-B2 Piperidine derivatives as NK3 receptor antagonists HOFFMANN-LA ROCHE INC. (US) 2012-12-04 — — US disclosed
US-20100256126-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS HOFFMANN-LA ROCHE, INC. 2010-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256126-A1 PIPERIDINE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS HTR3A, OPRL1, OPRK1 ALDH1A1 480/4885HPGD 1256/4885KDM4E 2560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback